| Company Name: |
Fedprotein |
| Tel: |
13041401126; 13041401126 |
| Email: |
3690410801@qq.com |
|
| | KRAS Antibody Chemical Properties |
| | KRAS Antibody Usage And Synthesis |
| Source | Rabbit | | Applications | KRAS antibody has been tested by ELISA, Western blot analysis, ICC/IF and Flow cytometry to assure specificity and reactivity. | | Reactivity | Human;Mouse;Rat | | Immunogen | Anti-human KRAS mAb, is derived from hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with a recombinant human KRAS protein 1-186 amino acids purified from E. coli. | | Background | Kirsten Rat Sarcoma Viral Oncogene, Isoform 2A (KRAS-2A) belongs to the small GTPase superfamily. The KRAS-2A protein is involved in a variety of malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Ras family members impact cell growth and differentiation events in a subcellular membrane compartmentalization-based signaling system under normal conditions. Oncogenic Ras can deregulate processes which control both cell proliferation and apoptosis. | | References | [1] Boguski, M.S. and McCormick, F. (1993) Nature 366, 643-54.
[2] Avruch, J. et al. (1994) Trends Biochem Sci 19, 279-83.
[3] Buday, L. and Downward, J. (1993) Cell 73, 611-20.
[4] Huang, D.C. et al. (1993) Mol Cell Biol 13, 2420-31.
[5] Bos, J.L. (1989) Cancer Res 49, 4682-9.
[6] Ma, J. and Karplus, M. (1997) J Mol Biol 274, 114-31. |
| | KRAS Antibody Preparation Products And Raw materials |
|